Screening and prevalence of peripheral neuropathy in type 2 diabetic outpatients: a randomized multicentre survey in 12 city hospitals of China

The 10‐g Semmes–Weinstein monofilament and 128‐Hz tuning fork examinations are considered simple and effective screening instruments for diabetic peripheral neuropathy. This study investigated the prevalence of diabetic peripheral neuropathy of combining both methods in type 2 diabetic outpatients in Chinese urban hospitals.

[1]  N. Chaturvedi,et al.  Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors , 2009, Diabetes Care.

[2]  J. Albers,et al.  Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.

[3]  D. De Bacquer,et al.  Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. , 2009, Diabetes & metabolism.

[4]  R. Pop-Busui,et al.  Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort , 2009, Journal of the peripheral nervous system : JPNS.

[5]  Anders Hamsten,et al.  Peripheral Sensory Neuropathy Associates With Micro- or Macroangiopathy , 2008, Diabetes Care.

[6]  N. Chaturvedi,et al.  Large fibre dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors , 2009 .

[7]  T. K. Young,et al.  Prevalence and Risk Factors for Neuropathy in a Canadian First Nation Community , 2008, Diabetes Care.

[8]  E. Gale.  Glucose control in the UKPDS: what did we learn? , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[9]  W. Houtum,et al.  Practical guidelines on the management and prevention of the diabetic foot , 2008, Diabetes/metabolism research and reviews.

[10]  J. Dora,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[11]  J. Albers,et al.  Subclinical Neuropathy Among Diabetes Control and Complications Trial Participants Without Diagnosable Neuropathy at Trial Completion , 2007, Diabetes Care.

[12]  J. Gross,et al.  Prevalence and characteristics of diabetic polyneuropathy in Passo Fundo, South of Brazil. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[13]  W. Jia,et al.  [Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy]. , 2006, Zhonghua yi xue za zhi.

[14]  H. Sone,et al.  Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.

[15]  Masamichi Okubo,et al.  Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. , 2004, Journal of diabetes and its complications.

[16]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[17]  P. Sorlie,et al.  Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. , 2004, Diabetes care.

[18]  R. Heine,et al.  Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[19]  B. Perkins,et al.  Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. , 2002, Diabetes research and clinical practice.

[20]  S. Tesfaye,et al.  Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy , 2001, Diabetologia.

[21]  B. Zinman,et al.  Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic , 2001 .

[22]  A. Boulton,et al.  The diabetic foot: a global view , 2000, Diabetes/metabolism research and reviews.

[23]  Epidemiological analysis of patients with Type 2 diabetes in France. , 2000, Journal of diabetes and its complications.

[24]  K. Birkeland,et al.  [Hypoglycemic treatment of type 2 diabetes]. , 2000, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[25]  L. Melton,et al.  Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. , 1999, Diabetes care.

[26]  I. Tkáč,et al.  Glycemic Control Is Related to the Electrophysiologic Severity of Diabetic Peripheral Sensorimotor Polyneuropathy , 1998, Diabetes Care.

[27]  A. Adler,et al.  Risk Factors for Diabetic Peripheral Sensory Neuropathy: Results of the Seattle Prospective Diabetic Foot Study , 1997, Diabetes Care.

[28]  J. Stephenson,et al.  Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study , 1996, Diabetologia.